$207.86
5.082.51%
At close: May 12, 5:00 PM EST
$207.71
-0.15-0.07%
After Hours: 6:44 PM EST
AbbVie Inc Earnings Estimates
ABBVNYSE
AbbVie Earnings Estimates, EPS & Revenue | NYSE:ABBV
AbbVie (ABBV) is scheduled to report Q2 earnings on July 30, 2026. Analysts estimate EPS of $3.76 and quarterly revenue of $16.76B.
In the most recent quarter (Q1), AbbVie reported EPS of $2.65, missing estimates of $2.66 by 0.00%. Revenue came in at $15.00B, exceeding the estimate of $14.73B by 0.02%.
Over the last 4 quarters, AbbVie has averaged an EPS surprise of 0.02% and a revenue surprise of 0.02%.
Earnings Date
Jul 30
EPS Estimate
$3.760
Quarterly Revenue Estimate
$16.76B
Annual Revenue
(as of Mar 31)
(as of Mar 31)
$62.82B
AbbVie Earnings History
Analyze the earnings history of AbbVie using advanced sorting and filters.
Loading calendar...
AbbVie (ABBV) Earnings Per Share
The chart below shows AbbVie's reported EPS compared to analyst estimates over recent quarters.
AbbVie (ABBV) Revenue
The chart below shows AbbVie's reported revenue compared to analyst estimates over recent quarters.
FAQ
When is AbbVie (NYSE:ABBV) reporting earnings?
AbbVie (ABBV) is scheduled to report earnings on July 30, 2026. The last reported earnings were for reported on April 29, 2026 for Q1.
What were the latest earnings per share (EPS) for AbbVie (NYSE:ABBV)?
The Actual EPS was $2.65, which missed the estimate of $2.66.
What were AbbVie’s (NYSE:ABBV) revenues?
The Actual Revenue was $15.00B, which beat the estimate of $14.73B.
